BiotechTube
Home/Artelo Biosciences/Mark Spring
MS

Mark Spring

Chief Financial Officer

Artelo Biosciences

Therapeutic Areas

OncologySupportive Care

Artelo Biosciences Pipeline

DrugIndicationPhase
ART27.13Cancer Anorexia-Cachexia Syndrome (CACS)Phase 2
ART26.12Solid Tumors (e.g., Prostate Cancer)Preclinical
ART12.11UndisclosedPreclinical

Leadership Team at Artelo Biosciences

GD
Gregory D. Gorgas
President, Chief Executive Officer, Director
SD
Steven D. Reich
Chief Medical Officer
AY
Andy Yates
Senior Vice President, Chief Scientific Officer
CM
Connie Matsui
Chair of the Board of Directors
DB
Douglas Blayney
Board Director
ME
Martin Emanuele
Board Director
View full Artelo Biosciences profile